Overview

RT001 in Amyotrophic Lateral Sclerosis

Status:
Recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

RT001-014 is a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects with Amyotrophic Lateral Sclerosis

Phase:

Phase 2

Details

Lead Sponsor:

Retrotope, Inc.